APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lung Tumor Ablation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lung Tumor Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442613024 July 2026196 pages

Choose your research edition.

Industry ResearchLung Tumor Ablation Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Tumor Ablation Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lung Tumor Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Tumor Ablation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Tumor Ablation Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Lung Tumor Ablation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung Tumor Ablation include Angiodynamics, Auris Health, Intuitive Surgica, Nanjing MICRO-TECH, Smith and Nephew, VISON Medical, Olympus, Boston Scientific and Broncus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lung Tumor Ablation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung Tumor Ablation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung Tumor Ablation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lung Tumor Ablation market size, projected growth trends, production technologies, key applications, and end-use industries.

Lung Tumor Ablation Segment by Company

Angiodynamics

Auris Health

Intuitive Surgica

Nanjing MICRO-TECH

Smith and Nephew

VISON Medical

Olympus

Boston Scientific

Broncus

LungCare

Medtronic

TIPC

Lung Tumor Ablation Segment by Type

Microwave Ablation (MWA)

Radiofrequency Ablation (RFA)

Cold Ablation

Others

Lung Tumor Ablation Segment by Application

Hospitals

Ambulatory Surgical Centers

Lung Tumor Ablation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Tumor Ablation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lung Tumor Ablation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung Tumor Ablation industry.

Chapter 3: Detailed analysis of Lung Tumor Ablation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Tumor Ablationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Microwave Ablation (MWA) Table 3. Key Players of Radiofrequency Ablation (RFA) Table 4. Key Players of Cold Ablation Table 3. Key Players of Others Table 4. Global Lung Tumor Ablation Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Ambulatory Surgical Centers Table 7. Global Lung Tumor Ablation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Lung Tumor Ablation Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Lung Tumor Ablation Market Share by Region (2021-2026) Table 10. Global Lung Tumor Ablation Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Lung Tumor Ablation Market Share by Region (2027-2032) Table 12. Lung Tumor Ablation Industry Trends Table 13. Lung Tumor Ablation Industry Drivers Table 14. Lung Tumor Ablation Industry Opportunities and Challenges Table 15. Lung Tumor Ablation Industry Restraints Table 16. Global Lung Tumor Ablation Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Lung Tumor Ablation Revenue Market Share by Company (2021-2026) Table 18. Global Lung Tumor Ablation Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lung Tumor Ablation Key Company Head Office and Area Served Table 20. Global Lung Tumor Ablation Company, Product Type & Application Table 21. Global Lung Tumor Ablation Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Lung Tumor Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Lung Tumor Ablation Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Lung Tumor Ablation Revenue Market Share by Type (2021-2026) Table 28. Global Lung Tumor Ablation Revenue Market Share by Type (2027-2032) Table 29. Global Lung Tumor Ablation Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Lung Tumor Ablation Revenue Market Share by Application (2021-2026) Table 33. Global Lung Tumor Ablation Revenue Market Share by Application (2027-2032) Table 34. Angiodynamics Company Information Table 35. Angiodynamics Business Overview Table 36. Angiodynamics Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Angiodynamics Lung Tumor Ablation Product Portfolio Table 38. Angiodynamics Recent Development Table 39. Auris Health Company Information Table 40. Auris Health Business Overview Table 41. Auris Health Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Auris Health Lung Tumor Ablation Product Portfolio Table 43. Auris Health Recent Development Table 44. Intuitive Surgica Company Information Table 45. Intuitive Surgica Business Overview Table 46. Intuitive Surgica Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Intuitive Surgica Lung Tumor Ablation Product Portfolio Table 48. Intuitive Surgica Recent Development Table 49. Nanjing MICRO-TECH Company Information Table 50. Nanjing MICRO-TECH Business Overview Table 51. Nanjing MICRO-TECH Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio Table 53. Nanjing MICRO-TECH Recent Development Table 54. Smith and Nephew Company Information Table 55. Smith and Nephew Business Overview Table 56. Smith and Nephew Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Smith and Nephew Lung Tumor Ablation Product Portfolio Table 58. Smith and Nephew Recent Development Table 59. VISON Medical Company Information Table 60. VISON Medical Business Overview Table 61. VISON Medical Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. VISON Medical Lung Tumor Ablation Product Portfolio Table 63. VISON Medical Recent Development Table 64. Olympus Company Information Table 65. Olympus Business Overview Table 66. Olympus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Olympus Lung Tumor Ablation Product Portfolio Table 68. Olympus Recent Development Table 69. Boston Scientific Company Information Table 70. Boston Scientific Business Overview Table 71. Boston Scientific Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Boston Scientific Lung Tumor Ablation Product Portfolio Table 73. Boston Scientific Recent Development Table 74. Broncus Company Information Table 75. Broncus Business Overview Table 76. Broncus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Broncus Lung Tumor Ablation Product Portfolio Table 78. Broncus Recent Development Table 79. LungCare Company Information Table 80. LungCare Business Overview Table 81. LungCare Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. LungCare Lung Tumor Ablation Product Portfolio Table 83. LungCare Recent Development Table 84. Medtronic Company Information Table 85. Medtronic Business Overview Table 86. Medtronic Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Medtronic Lung Tumor Ablation Product Portfolio Table 88. Medtronic Recent Development Table 89. TIPC Company Information Table 90. TIPC Business Overview Table 91. TIPC Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. TIPC Lung Tumor Ablation Product Portfolio Table 93. TIPC Recent Development Table 94. North America Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 95. North America Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 96. North America Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 97. North America Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 98. North America Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Lung Tumor Ablation Market Size by Country (2021-2026) Table 100. North America Lung Tumor Ablation Market Size by Country (2027-2032) Table 101. Europe Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 102. Europe Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 103. Europe Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 104. Europe Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 105. Europe Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Lung Tumor Ablation Market Size by Country (2021-2026) Table 107. Europe Lung Tumor Ablation Market Size by Country (2027-2032) Table 108. China Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 109. China Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 110. China Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 111. China Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 113. Asia Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 114. Asia Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 115. Asia Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Lung Tumor Ablation Market Size by Country (2021-2026) Table 118. Asia Lung Tumor Ablation Market Size by Country (2027-2032) Table 119. South America, Middle East & Africa Lung Tumor Ablation Market Size by Type (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Lung Tumor Ablation Market Size by Type (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Lung Tumor Ablation Market Size by Application (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Lung Tumor Ablation Market Size by Application (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2021-2026) Table 125. South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Lung Tumor Ablation Product Image Figure 2. Global Lung Tumor Ablation Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lung Tumor Ablation Market Share by Type: 2025 VS 2032 Figure 4. Microwave Ablation (MWA) Image Figure 5. Radiofrequency Ablation (RFA) Image Figure 6. Cold Ablation Image Figure 7. Others Image Figure 8. Global Lung Tumor Ablation Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Lung Tumor Ablation Market Share by Application: 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Ambulatory Surgical Centers Image Figure 12. Global Lung Tumor Ablation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 14. Global Lung Tumor Ablation Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Lung Tumor Ablation Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Lung Tumor Ablation Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Lung Tumor Ablation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lung Tumor Ablation Revenue Market Share by Type (2021-2032) Figure 21. Global Lung Tumor Ablation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Lung Tumor Ablation Revenue Market Share by Application (2021-2032) Figure 23. North America Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 24. North America Lung Tumor Ablation Market Share by Type (2021-2032) Figure 25. North America Lung Tumor Ablation Market Share by Application (2021-2032) Figure 26. North America Lung Tumor Ablation Market Share by Country (2021-2032) Figure 27. United States Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 28. Canada Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 30. Europe Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 31. Europe Lung Tumor Ablation Market Share by Type (2021-2032) Figure 32. Europe Lung Tumor Ablation Market Share by Application (2021-2032) Figure 33. Europe Lung Tumor Ablation Market Share by Country (2021-2032) Figure 34. Germany Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 35. France Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 37. Italy Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 38. Russia Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 40. China Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 41. China Lung Tumor Ablation Market Share by Type (2021-2032) Figure 42. China Lung Tumor Ablation Market Share by Application (2021-2032) Figure 43. Asia Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 44. Asia Lung Tumor Ablation Market Share by Type (2021-2032) Figure 45. Asia Lung Tumor Ablation Market Share by Application (2021-2032) Figure 46. Asia Lung Tumor Ablation Market Share by Country (2021-2032) Figure 47. Japan Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 51. India Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 52. Australia Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Lung Tumor Ablation Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Lung Tumor Ablation Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Lung Tumor Ablation Market Share by Country (2021-2032) Figure 57. Brazil Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 62. UAE Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 64. Chile Lung Tumor Ablation Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Microwave Ablation (MWA)
  • Radiofrequency Ablation (RFA)
  • Cold Ablation
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Angiodynamics
  • Auris Health
  • Intuitive Surgica
  • Nanjing MICRO-TECH
  • Smith and Nephew
  • VISON Medical
  • Olympus
  • Boston Scientific
  • Broncus
  • LungCare
  • Medtronic
  • TIPC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lung Tumor Ablation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Microwave Ablation (MWA)
  5. 1.2.3 Radiofrequency Ablation (RFA)
  6. 1.2.4 Cold Ablation
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Lung Tumor Ablation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Ambulatory Surgical Centers
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Lung Tumor Ablation Growth Trends by Region
  14. 1.5.1 Global Lung Tumor Ablation Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Lung Tumor Ablation Market Size by Region (2021-2026)
  16. 1.5.3 Lung Tumor Ablation Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Lung Tumor Ablation Market Dynamics
  1. 2.1 Lung Tumor Ablation Industry Trends
  2. 2.2 Lung Tumor Ablation Industry Drivers
  3. 2.3 Lung Tumor Ablation Industry Opportunities and Challenges
  4. 2.4 Lung Tumor Ablation Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lung Tumor Ablation Revenue by Company (2021-2026)
  2. 3.2 Global Lung Tumor Ablation Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lung Tumor Ablation Key Company Head office and Area Served
  4. 3.4 Global Lung Tumor Ablation Company, Product Type & Application
  5. 3.5 Global Lung Tumor Ablation Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lung Tumor Ablation Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lung Tumor Ablation Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lung Tumor Ablation Tier 1, Tier 2, and Tier 3
4 Lung Tumor Ablation Market by Type
  1. 4.1 Global Lung Tumor Ablation Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lung Tumor Ablation Market Size by Type (2021-2032)
  3. 4.3 Global Lung Tumor Ablation Market Size Share by Type (2021-2032)
5 Lung Tumor Ablation Market by Application
  1. 5.1 Global Lung Tumor Ablation Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lung Tumor Ablation Market Size by Application (2021-2032)
  3. 5.3 Global Lung Tumor Ablation Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Angiodynamics
  2. 6.1.1 Angiodynamics Company Information
  3. 6.1.2 Angiodynamics Business Overview
  4. 6.1.3 Angiodynamics Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Angiodynamics Lung Tumor Ablation Product Portfolio
  6. 6.1.5 Angiodynamics Recent Developments
  7. 6.2 Auris Health
  8. 6.2.1 Auris Health Company Information
  9. 6.2.2 Auris Health Business Overview
  10. 6.2.3 Auris Health Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Auris Health Lung Tumor Ablation Product Portfolio
  12. 6.2.5 Auris Health Recent Developments
  13. 6.3 Intuitive Surgica
  14. 6.3.1 Intuitive Surgica Company Information
  15. 6.3.2 Intuitive Surgica Business Overview
  16. 6.3.3 Intuitive Surgica Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Intuitive Surgica Lung Tumor Ablation Product Portfolio
  18. 6.3.5 Intuitive Surgica Recent Developments
  19. 6.4 Nanjing MICRO-TECH
  20. 6.4.1 Nanjing MICRO-TECH Company Information
  21. 6.4.2 Nanjing MICRO-TECH Business Overview
  22. 6.4.3 Nanjing MICRO-TECH Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio
  24. 6.4.5 Nanjing MICRO-TECH Recent Developments
  25. 6.5 Smith and Nephew
  26. 6.5.1 Smith and Nephew Company Information
  27. 6.5.2 Smith and Nephew Business Overview
  28. 6.5.3 Smith and Nephew Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Smith and Nephew Lung Tumor Ablation Product Portfolio
  30. 6.5.5 Smith and Nephew Recent Developments
  31. 6.6 VISON Medical
  32. 6.6.1 VISON Medical Company Information
  33. 6.6.2 VISON Medical Business Overview
  34. 6.6.3 VISON Medical Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 VISON Medical Lung Tumor Ablation Product Portfolio
  36. 6.6.5 VISON Medical Recent Developments
  37. 6.7 Olympus
  38. 6.7.1 Olympus Company Information
  39. 6.7.2 Olympus Business Overview
  40. 6.7.3 Olympus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Olympus Lung Tumor Ablation Product Portfolio
  42. 6.7.5 Olympus Recent Developments
  43. 6.8 Boston Scientific
  44. 6.8.1 Boston Scientific Company Information
  45. 6.8.2 Boston Scientific Business Overview
  46. 6.8.3 Boston Scientific Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boston Scientific Lung Tumor Ablation Product Portfolio
  48. 6.8.5 Boston Scientific Recent Developments
  49. 6.9 Broncus
  50. 6.9.1 Broncus Company Information
  51. 6.9.2 Broncus Business Overview
  52. 6.9.3 Broncus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Broncus Lung Tumor Ablation Product Portfolio
  54. 6.9.5 Broncus Recent Developments
  55. 6.10 LungCare
  56. 6.10.1 LungCare Company Information
  57. 6.10.2 LungCare Business Overview
  58. 6.10.3 LungCare Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 LungCare Lung Tumor Ablation Product Portfolio
  60. 6.10.5 LungCare Recent Developments
  61. 6.11 Medtronic
  62. 6.11.1 Medtronic Company Information
  63. 6.11.2 Medtronic Business Overview
  64. 6.11.3 Medtronic Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Medtronic Lung Tumor Ablation Product Portfolio
  66. 6.11.5 Medtronic Recent Developments
  67. 6.12 TIPC
  68. 6.12.1 TIPC Company Information
  69. 6.12.2 TIPC Business Overview
  70. 6.12.3 TIPC Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 TIPC Lung Tumor Ablation Product Portfolio
  72. 6.12.5 TIPC Recent Developments
7 North America
  1. 7.1 North America Lung Tumor Ablation Market Size (2021-2032)
  2. 7.2 North America Lung Tumor Ablation Market Size by Type
  3. 7.2.1 North America Lung Tumor Ablation Market Size by Type (2021-2026)
  4. 7.2.2 North America Lung Tumor Ablation Market Size by Type (2027-2032)
  5. 7.2.3 North America Lung Tumor Ablation Market Share by Type (2021-2032)
  6. 7.3 North America Lung Tumor Ablation Market Size by Application
  7. 7.3.1 North America Lung Tumor Ablation Market Size by Application (2021-2026)
  8. 7.3.2 North America Lung Tumor Ablation Market Size by Application (2027-2032)
  9. 7.3.3 North America Lung Tumor Ablation Market Share by Application (2021-2032)
  10. 7.4 North America Lung Tumor Ablation Market Size by Country
  11. 7.4.1 North America Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lung Tumor Ablation Market Size by Country (2021-2026)
  13. 7.4.3 North America Lung Tumor Ablation Market Size by Country (2027-2032)
  14. 7.4.4 North America Lung Tumor Ablation Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lung Tumor Ablation Market Size (2021-2032)
  2. 8.2 Europe Lung Tumor Ablation Market Size by Type
  3. 8.2.1 Europe Lung Tumor Ablation Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lung Tumor Ablation Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lung Tumor Ablation Market Share by Type (2021-2032)
  6. 8.3 Europe Lung Tumor Ablation Market Size by Application
  7. 8.3.1 Europe Lung Tumor Ablation Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lung Tumor Ablation Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lung Tumor Ablation Market Share by Application (2021-2032)
  10. 8.4 Europe Lung Tumor Ablation Market Size by Country
  11. 8.4.1 Europe Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lung Tumor Ablation Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lung Tumor Ablation Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lung Tumor Ablation Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lung Tumor Ablation Market Size (2021-2032)
  2. 9.2 China Lung Tumor Ablation Market Size by Type
  3. 9.2.1 China Lung Tumor Ablation Market Size by Type (2021-2026)
  4. 9.2.2 China Lung Tumor Ablation Market Size by Type (2027-2032)
  5. 9.2.3 China Lung Tumor Ablation Market Share by Type (2021-2032)
  6. 9.3 China Lung Tumor Ablation Market Size by Application
  7. 9.3.1 China Lung Tumor Ablation Market Size by Application (2021-2026)
  8. 9.3.2 China Lung Tumor Ablation Market Size by Application (2027-2032)
  9. 9.3.3 China Lung Tumor Ablation Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lung Tumor Ablation Market Size (2021-2032)
  2. 10.2 Asia Lung Tumor Ablation Market Size by Type
  3. 10.2.1 Asia Lung Tumor Ablation Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lung Tumor Ablation Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lung Tumor Ablation Market Share by Type (2021-2032)
  6. 10.3 Asia Lung Tumor Ablation Market Size by Application
  7. 10.3.1 Asia Lung Tumor Ablation Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lung Tumor Ablation Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lung Tumor Ablation Market Share by Application (2021-2032)
  10. 10.4 Asia Lung Tumor Ablation Market Size by Country
  11. 10.4.1 Asia Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lung Tumor Ablation Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lung Tumor Ablation Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lung Tumor Ablation Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lung Tumor Ablation Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lung Tumor Ablation Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lung Tumor Ablation Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lung Tumor Ablation Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lung Tumor Ablation Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lung Tumor Ablation Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lung Tumor Ablation Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lung Tumor Ablation Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lung Tumor Ablation Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lung Tumor Ablation Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lung Tumor Ablation Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lung Tumor Ablation Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst